Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database
Language
EN
Article de revue
This item was published in
Therapeutic Advances in Neurological Disorders. 2024-09-12, vol. 17, p. 1-2
English Keywords
Disproportionality Analysis
Drug Repurposing
Pharmacovigilance